Brands: Glyrx-Pf · Glycopyrrolate
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 10 | SUPPLYING |
| American Regent, Inc. | unknown | 4 | SUPPLYING |
| Exela Pharma Sciences, LLC | unknown | 4 | SUPPLYING |
| AuroMedics Pharma LLC | unknown | 4 | SUPPLYING |
| Piramal Critical Care Inc | unknown | 4 | SUPPLYING |
| Henry Schein, Inc. | relabeler | 4 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 3 | SUPPLYING |
| ProPharma Distribution | relabeler | 3 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 3 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 2 | SUPPLYING |
| Civica, Inc | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Glycopyrrolate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia.
Glycopyrrolate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia.
Presence of Particulate Matter: Hair was found in product — Recalling firm: Fresenius Kabi USA, LLC — Nationwide within in the USA
Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples). — Recalling firm: AuroMedics Pharma LLC — Ohio, Louisiana, Mississippi
